Recap: Ekso Bionics Holdings Q4 Earnings
Portfolio Pulse from Benzinga Insights
Ekso Bionics Holdings (NASDAQ:EKSO) reported Q4 earnings with an EPS of $-0.22, missing estimates by -100.0% against an expected $-0.11. Revenue increased by $1.30 million from the previous year. The company had previously beaten EPS estimates in Q3 2023, which led to a 6.0% share price increase the following day.
March 04, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ekso Bionics Holdings reported a significant miss in Q4 earnings with an EPS of $-0.22, which was 100% below the estimated $-0.11. However, revenue saw an increase from the previous year.
The significant miss in EPS estimates for Q4 is likely to negatively impact investor sentiment in the short term, especially considering the stock's positive reaction to the previous quarter's earnings beat. The increase in revenue may provide some buffer, but the missed earnings expectation is a critical factor.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100